Normal insecurities, healthy insecurities

The Insecure American: How We Got Here and What We Should Do about It

Volumn , Issue , 2009, Pages 163-181

  Dumit, Joseph ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84887765235     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (33)

1. Centers for Disease Prevention and Control, "Are You the Picture of Health?" campaign for colorectal cancer screening, www.cdc.gov/screenforlife.
2. Andrew S. Rowland et al., "Prevalence of Medication Treatment for Attention Deficit-Hyperactivity Disorder among Elementary School Children in Johnston County, North Carolina," American Journal of Public Health 92 (February 2002): 231-34.
3. Centers for Medicare and Medicaid Services, "NHE Fact Sheet," www.cms.hhs.gov/NationalHealthExpendData/ (accessed February 10, 2009).
4. Marcia Angell, The Truth about the Drug Companies: How They Deceive Us and What to Do about It (New York: Random House, 2005);
5. Jerry Avorn, Powerful Medicines: The Benefits, Risks and Costs of Prescription Drugs (New York: Vintage, 2005);
6. Ray Moynihan, Selling Sickness: How the World's Biggest Pharmaceutical Companies Are Turning Us All into Patients (New York: Nation Books, 2006);
7. David Healy, Let Them Eat Prozac: The Unhealthy Relationship between the Pharmaceutical Industry and Depression (New York: NYU Press, 2006);
8. Susan Kelleher and Duff Wilson, "Suddenly Sick," Seattle Times, June 26-30, 2005.
9. Robert Hahn, Sickness and Healing (New Haven, CT: Yale University Press, 1995), 31.
10. H. Gilbert Welch, Should I Be Tested for Cancer? Maybe Not, and Here's Why (Berkeley: University of California Press, 2006).
11. Georges Canguilhem, The Normal and the Pathological, trans. Carolyn R. Fawcett and Robert S. Cohen (New York: Zone Books, 1989), 198-200.
12. Stephen Smith, "New Guidelines See Many More at Risk on Blood Pressure," Boston Globe, May 15, 2003.
13. Elizabeth Agnvall, "Making Us (Nearly) Sick; A Majority of Americans Are Now Considered to Have at Least One 'Pre-Disease' or 'Borderline' Condition. Is This Any Way to Treat Us?" Washington Post, February 10, 2004, F01.
14. Peter D. Kramer, Listening to Prozac: A Psychiatrist Explores Antidepressant Drugs and the Remaking of the Self (New York: Viking, 1993).
15. Roger S. Blumenthal, "Keeping Your Heart Healthy Is a Risky Business," Time, September 12, 2005,
16. D.Q. Healy, "Life-Saving Pill Goes Begging: Cardiologists Puzzled at Underuse of Cholesterol- Busting Drug," SouthCoast Today, August 10, 1999.
17. David Healy, The Creation of Psychopharmacology (Cambridge, MA: Harvard University Press, 2002), 350.
18. "How Many Nations Fluoridate Their Water?" Fluoride Action Network, www.fluoridealert.org/ RFW-nations.htm.
19. Robin Henig, The People's Health (Washington, DC: Joseph Henry Press, 1997), 85.
20. D. G. Manuel et al., "Effectiveness and Efficiency of Different Guidelines on Statin Treatment for Preventing Deaths from Coronary Heart Disease: Modelling Study," British Medical Journal 332, no. 7555 (2006): 1419.
21. N. Wald and M. Law, "A Strategy to Reduce Cardiovascular Disease by More Than 80%," British Medical Journal 326, no. 7404 (2003): 1419.
22. D.F. Klein et al., "Improving Clinical Trials: American Society of Clinical Psychopharmacology Recommendations," Archives of General Psychiatry 59 (2002): 272-78.
23. Ernst & Young LLP, "Contract Research: Contracted for Trouble?" R&D Directions 12, no. 5 (2006).
24. R. M. Califf, "Benefit the Patient, Manage the Risk: A System Goal." Pharmacoepidemiology and Drug Safety 13 (2004): 269-76.
25. S. Ramspacher, "Engaging the Untreated: Identifying and Motivating Your Best Prospects," DTC Perspectives (2004).
26. R. Daly and M. Kolassa, "Start Earlier, Sell More, Sell Longer," Pharmaceutical Executive (March 2004): 30-38.
27. Cutting Edge Information, Cardiovascular Marketing: Budgets, Staffing and Strategy, PH59 (Research Triangle Park, NC: Cutting Edge Information, 2004).
28. Windhover Information, "Moving beyond Market Share," In Vivo: The Business and Medicine Report 16, no. 3 (2002): 69.
29. Jay Bolling, "DTC: A Strategy for Every Stage," Pharmaceutical Executive 23, no. 11 (2003): 110.
30. K. J. Aikin, "Direct-to-Consumer Advertising of Prescription Drugs: Physician Survey Preliminary Results," January 13, 2003, www.fda.gov/cder/ddmac/globalsummit2003.
31. V. Realto, "Prilosec Spot Hits All the Hot Buttons," Pharmaceutical Executive (May 1998), 14-19.
32. Dorothy Smith, "It's Our Health . . . and We Want More Than Advertising," Pharmaceutical Executive (July 1998), 23.
33. Realto, "Prilosec Spot Hits All the Hot Buttons."